Company October Pharma S.A.E

OCPH

EGS380R1C018

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
100 ^EGP	0.00%		0.00%	0.00%

Mar. 10	October Pharma S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	October Pharma S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

October Pharma S.A.E. specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of cardiovascular, diabetic, gastroenterological, inflammatory, infectious, metabolic, viral, urological, gynecological, dermatological, dental diseases, etc.

At the end of 2020, the group had a production site located in Egypt.

EGP in Million	2019	Weight	2020	Weight	Delta
Pharmaceuticals and Drugs 100.0 %	523	100.0 %	543	100.0 %	+3.88%

EGP in Million	2019	Weight	2020	Weight	Delta
Egypt 100.0 %	523	100.0 %	543	100.0 %	+3.88%

Managers	Title	Age	Since
Hesham Abdul Aziz El Sayed Soliman CEO	Chief Executive Officer	-	-
Tamer Ahmed DFI	Director of Finance/CFO	-	-
Hassan Abdul Wahab CTO	Chief Tech/Sci/R&D Officer	-	-
Adil Abdul Maqsoud Said SEC	Corporate Secretary	-	-
Wahid Abdul Ghafar Mujahid AUD	Comptroller/Controller/Auditor	-	-
Hossam Salah El-Din HRO	Human Resources Officer	-	-

Members of the board	Title	Age	Since
Jamal Salah El Din Mahmoud Awad BRD	Director/Board Member	-	18-10-30
Adnan Talal Al-Ghazzawi BRD	Director/Board Member	-	-
Hesham Abdul Aziz El Sayed Soliman CEO	Chief Executive Officer	-	-
Gamal Hafez Tekal Al Shishi CHM	Chairman	-	-
Amro bin Abdel Aziz Algalal BRD	Director/Board Member	-	-
Mouhsen Ali Mohamed BRD	Director/Board Member	-	-
Ahmed Mahmoud Farag BRD	Director/Board Member	-	-
Saied Khalfan Mohamed Al Marar BRD	Director/Board Member	-	-
Fattouh Mohamed Salama BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	12,000,000	1,381,476 ( 11.51 %)	0	11.51 %

October Pharma Co.

1st Industrial Zone Street 25, 6th of October City

12566, Cairo

http://www.octoberpharma.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
OCTOBER PHARMA S.A.E	0.00%	25.05M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals